Professor Anne Dickinson is Professor of Marrow Transplant Biology at Newcastle University and has a wealth of experience in application of cellular products for clinical use. Her teaching and research is focused on non-HLA immunogenetics in haematopoietic stem cell transplantation, and the immunopathology of graft-versus-host disease using an in vitro human skin explant model. The scope of Anne's career has enabled her to develop much experience in manipulation of haematopoietic stem cells for clinical use, and more recently in HTA & MHRA audit and license procedures.
Professor James Shaw is Professor of Regenerative Medicine in Diabetes at Newcastle University and Chair of the UK Islet Transplant Consortium, with extensive experience of using clean rooms for allogeneic transplant products.
Professor Matthew Collin is Clinical Director of the Adult Bone Marrow Transplant unit, which currently carries out over 100 transplants, including autologous and allogeneic transplants, per year.
Quality and production staff
The Cellular Therapies Facility team also includes Quality Assurance and Quality Control Managers, Production Managers and state-registered clinical scientists. All have experience in either the bio-manufacturing industry or haematopoietic stem cell manipulation for clinical use.
The Facility also has a dedicated Qualified Person (QP) for batch release of products.